In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading ->
The World Health Organization today admitted to an unusual procedure to set up a debate on the health implications of a UN treaty on sharing of benefits from genetic resources. The new agenda item proposed by the WHO director general was accepted by the WHO Board today, but with member states questioning the governance of the move. Continue reading ->
The World Health Organization is exploring ways to expand relationships with non-governmental organizations, including broader collaborations on key global health priorities and a possible informal consultation with civil society every year, Director General Dr Tedros Adhanom Gheyebresus told WHO’s Executive Board today. Continue reading ->
Preventable environmental risks lead to a yearly death toll of 13 million people, 7 million of which are caused by air pollution, according to a World Health Organization report presented yesterday to its members attending the organisation’s Executive Board. Time is of the essence and the WHO draft global strategy on health, environment, and climate change received broad support, as well as a draft action plan for small island developing states, particularly vulnerable to climate change. Continue reading ->
Representatives of Italy and the United States today asked the World Health Organization to remove a summary of evidence on how taxes on sugar-sweetened drinks may help reduce unhealthy sugar consumption from its latest progress report on tackling non-communicable disease (NCDs). Continue reading ->
A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs. Continue reading ->
Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading ->
After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading ->
Measurable outputs are a key element of the World Health Organization transformation and its “triple billion” target. Last week, WHO Executive Board discussed the Impact Framework, a key measurement system. Board members asked clarifications on indicators and underlined the challenge of data collection in many countries. A consultation with country experts is expected to be held before the May World Health Assembly. Continue reading ->
The World Health Organization Executive Board meeting consists of many lengthy and arduous sessions. In the spirit of increasing physical activity to address non-communicable diseases - and possibly help delegates move to successful conclusions - here is a glimpse of a WHO physical exercise break from this week, set to a Chinese dance video. Continue reading ->